VANGUARD GROUP INC

Holdings History for Neurogene Inc. - Common Stock, $0.000001 par value (NGNE)

Symbol: NGNE on Nasdaq
Investment type: Equity / Common Stock, $0.000001 par value

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	+0%	$13,525,383	656,572	+51,961	+8.6%	$20.60	Q4 2025
30 Sep 2025	0%	-0%	$10,477,909	604,611	-5,726	-0.94%	$17.33	Q3 2025
30 Jun 2025	0%	-0%	$9,124,538	610,337	-7,598	-1.2%	$14.95	Q2 2025
31 Mar 2025	0%	+0%	$7,236,018	617,935	+49,919		$11.71	Q1 2025
31 Dec 2024	0%	-0%	$12,984,846	568,016	-8,144	-1.4%	$22.86	Q4 2024
30 Sep 2024	0%	+0%	$24,175,673	576,160	+12,635	+2.2%	$41.96	Q3 2024
30 Jun 2024	0%	+0%	$20,506,675	563,525	+56,042	+11%	$36.39	Q2 2024
31 Mar 2024	0%	+0%	$25,830,884	507,483	+457,062	+906%	$50.90	Q1 2024
31 Dec 2023	0%	+0%	$977,159	50,421	+50,421	NEW	$19.38	Q4 2023

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.